BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
Teva
AstraZeneca
Chinese Patent Office
Novartis
McKesson
Baxter
Cantor Fitzgerald
Citi
QuintilesIMS

Generated: January 19, 2018

DrugPatentWatch Database Preview

LAMISIL AT Drug Profile

« Back to Dashboard

Which patents cover Lamisil At, and when can generic versions of Lamisil At launch?

Lamisil At is a drug marketed by Novartis and is included in two NDAs.

The generic ingredient in LAMISIL AT is terbinafine hydrochloride. There are twenty-six drug master file entries for this compound. Fifty-six suppliers are listed for this compound. Additional details are available on the terbinafine hydrochloride profile page.

US Patents and Regulatory Information for LAMISIL AT

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis LAMISIL AT terbinafine GEL;TOPICAL 021958-001 Jul 24, 2006 OTC Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Novartis LAMISIL AT terbinafine hydrochloride SOLUTION;TOPICAL 021124-001 Mar 17, 2000 OTC Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Novartis LAMISIL AT terbinafine hydrochloride SPRAY;TOPICAL 021124-002 Mar 17, 2000 OTC Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for LAMISIL AT

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novartis LAMISIL AT terbinafine hydrochloride SOLUTION;TOPICAL 021124-001 Mar 17, 2000 ➤ Subscribe ➤ Subscribe
Novartis LAMISIL AT terbinafine hydrochloride SPRAY;TOPICAL 021124-002 Mar 17, 2000 ➤ Subscribe ➤ Subscribe
Novartis LAMISIL AT terbinafine GEL;TOPICAL 021958-001 Jul 24, 2006 ➤ Subscribe ➤ Subscribe
Novartis LAMISIL AT terbinafine hydrochloride SPRAY;TOPICAL 021124-002 Mar 17, 2000 ➤ Subscribe ➤ Subscribe
Novartis LAMISIL AT terbinafine GEL;TOPICAL 021958-001 Jul 24, 2006 ➤ Subscribe ➤ Subscribe
Novartis LAMISIL AT terbinafine hydrochloride SOLUTION;TOPICAL 021124-001 Mar 17, 2000 ➤ Subscribe ➤ Subscribe
Novartis LAMISIL AT terbinafine hydrochloride SOLUTION;TOPICAL 021124-001 Mar 17, 2000 ➤ Subscribe ➤ Subscribe
Novartis LAMISIL AT terbinafine GEL;TOPICAL 021958-001 Jul 24, 2006 ➤ Subscribe ➤ Subscribe
Novartis LAMISIL AT terbinafine hydrochloride SPRAY;TOPICAL 021124-002 Mar 17, 2000 ➤ Subscribe ➤ Subscribe
Novartis LAMISIL AT terbinafine hydrochloride SOLUTION;TOPICAL 021124-001 Mar 17, 2000 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Teva
AstraZeneca
Farmers Insurance
Accenture
QuintilesIMS
Chinese Patent Office
Baxter
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot